// STATE LEGISLATION TRACKER

Oklahoma SB 1418: Physician Advisory Committee; medical examination and treatment; removing authority to establish parameters for certain

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Oklahoma
Bill: SB 1418
Filed: 2020-02-03
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Oklahoma SB1418 was a workers' compensation bill about the Physician Advisory Committee and treatment guidelines for injured workers. Based on the title, subjects, and available status, it does not appear to regulate compounded peptides, off-label prescribing, telehealth prescribing, NP or naturopath scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No apparent change to patient access to compounded peptides
No apparent change to off-label prescribing rules
No apparent change to telehealth peptide prescribing
No apparent change to NP or naturopath peptide scope
No apparent change to 503A or 503B compounding

What to Watch For

Note The bill appears limited to workers' compensation medical treatment guidelines.

Note It could matter only if peptide treatment were claimed as workers' comp care.

Note Because the bill died, it did not create current Oklahoma peptide rules.

Where the Bill Stands

The bill passed the Oklahoma Senate in 2020 but died in the House after second reading on May 6, 2020.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws